Alex Thompson
Stock Analyst at Stifel
(1.12)
# 3,482
Out of 4,832 analysts
34
Total ratings
46.15%
Success rate
-12.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Thompson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics | Maintains: Hold | $22 → $23 | $21.08 | +9.11% | 3 | May 2, 2025 | |
| THRD Third Harmonic Bio | Downgrades: Hold | $23 → $5 | $5.16 | -3.10% | 2 | Mar 28, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $36 | $3.60 | +900.00% | 1 | Mar 25, 2025 | |
| CRNX Crinetics Pharmaceuticals | Initiates: Buy | $60 | $31.29 | +91.75% | 1 | Mar 25, 2025 | |
| ASND Ascendis Pharma | Maintains: Buy | $200 → $207 | $157.20 | +31.68% | 2 | Nov 15, 2024 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $49 | $9.71 | +404.63% | 1 | Oct 11, 2024 | |
| ARGX argenx SE | Maintains: Buy | $485 → $500 | $532.27 | -6.06% | 4 | Jun 24, 2024 | |
| SYRE Spyre Therapeutics | Reiterates: Buy | $36 → $54 | $14.81 | +264.74% | 2 | Mar 26, 2024 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $44 | $18.94 | +132.31% | 1 | Feb 15, 2024 | |
| VTYX Ventyx Biosciences | Maintains: Hold | $6 → $2 | $1.18 | +69.49% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $36.98 | +86.59% | 2 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $2 → $1 | $1.19 | -15.61% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.38 | +223.10% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $0.75 | +5,231.91% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $34 | $13.78 | +146.73% | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.37 | +2,317.58% | 1 | Dec 14, 2022 |
Travere Therapeutics
May 2, 2025
Maintains: Hold
Price Target: $22 → $23
Current: $21.08
Upside: +9.11%
Third Harmonic Bio
Mar 28, 2025
Downgrades: Hold
Price Target: $23 → $5
Current: $5.16
Upside: -3.10%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $36
Current: $3.60
Upside: +900.00%
Crinetics Pharmaceuticals
Mar 25, 2025
Initiates: Buy
Price Target: $60
Current: $31.29
Upside: +91.75%
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $200 → $207
Current: $157.20
Upside: +31.68%
Oruka Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $49
Current: $9.71
Upside: +404.63%
argenx SE
Jun 24, 2024
Maintains: Buy
Price Target: $485 → $500
Current: $532.27
Upside: -6.06%
Spyre Therapeutics
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $14.81
Upside: +264.74%
Dianthus Therapeutics
Feb 15, 2024
Initiates: Buy
Price Target: $44
Current: $18.94
Upside: +132.31%
Ventyx Biosciences
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $1.18
Upside: +69.49%
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $36.98
Upside: +86.59%
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $1.19
Upside: -15.61%
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $12.38
Upside: +223.10%
Aug 9, 2023
Initiates: Buy
Price Target: $40
Current: $0.75
Upside: +5,231.91%
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $13.78
Upside: +146.73%
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $1.37
Upside: +2,317.58%